

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | polyol transport (GO:0015791) | 9.86667647 |
| 2 | drug transport (GO:0015893) | 9.18633747 |
| 3 | organic cation transport (GO:0015695) | 8.72000596 |
| 4 | phosphate ion transport (GO:0006817) | 8.35352499 |
| 5 | exogenous drug catabolic process (GO:0042738) | 7.85594358 |
| 6 | lysine catabolic process (GO:0006554) | 7.78531168 |
| 7 | lysine metabolic process (GO:0006553) | 7.78531168 |
| 8 | actin filament depolymerization (GO:0030042) | 7.64165053 |
| 9 | collecting duct development (GO:0072044) | 7.56870900 |
| 10 | drug catabolic process (GO:0042737) | 7.48148089 |
| 11 | glyoxylate metabolic process (GO:0046487) | 7.31316183 |
| 12 | vitamin A metabolic process (GO:0006776) | 7.20094230 |
| 13 | quaternary ammonium group transport (GO:0015697) | 7.19037904 |
| 14 | phosphate ion transmembrane transport (GO:0035435) | 6.77749107 |
| 15 | cysteine metabolic process (GO:0006534) | 6.64783360 |
| 16 | tricarboxylic acid metabolic process (GO:0072350) | 6.24047108 |
| 17 | nephron epithelium development (GO:0072009) | 6.17486537 |
| 18 | cell volume homeostasis (GO:0006884) | 6.17345269 |
| 19 | response to mercury ion (GO:0046689) | 6.17171473 |
| 20 | gamma-aminobutyric acid transport (GO:0015812) | 6.12627146 |
| 21 | nonribosomal peptide biosynthetic process (GO:0019184) | 5.99055152 |
| 22 | cardiovascular system development (GO:0072358) | 5.86959174 |
| 23 | vitamin D metabolic process (GO:0042359) | 5.71643292 |
| 24 | regulation of protein polyubiquitination (GO:1902914) | 5.60709246 |
| 25 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic proc | 5.50270471 |
| 26 | response to water (GO:0009415) | 5.49468393 |
| 27 | short-chain fatty acid metabolic process (GO:0046459) | 5.48270988 |
| 28 | excretion (GO:0007588) | 5.46697364 |
| 29 | glutathione biosynthetic process (GO:0006750) | 5.38979046 |
| 30 | trivalent inorganic anion homeostasis (GO:0072506) | 5.35069707 |
| 31 | phosphate ion homeostasis (GO:0055062) | 5.35069707 |
| 32 | aspartate family amino acid catabolic process (GO:0009068) | 5.32545173 |
| 33 | toxin transport (GO:1901998) | 5.32112632 |
| 34 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 5.29170975 |
| 35 | branched-chain amino acid metabolic process (GO:0009081) | 5.22698906 |
| 36 | renal absorption (GO:0070293) | 5.18004552 |
| 37 | amino-acid betaine transport (GO:0015838) | 5.06520210 |
| 38 | carnitine transport (GO:0015879) | 5.06520210 |
| 39 | positive regulation of catenin import into nucleus (GO:0035413) | 5.03640450 |
| 40 | cellular response to electrical stimulus (GO:0071257) | 5.01519601 |
| 41 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.94543736 |
| 42 | L-phenylalanine metabolic process (GO:0006558) | 4.94543736 |
| 43 | negative regulation of cholesterol transport (GO:0032375) | 4.94242535 |
| 44 | negative regulation of sterol transport (GO:0032372) | 4.94242535 |
| 45 | proline metabolic process (GO:0006560) | 4.93987180 |
| 46 | hyperosmotic response (GO:0006972) | 4.93213269 |
| 47 | cellular modified amino acid catabolic process (GO:0042219) | 4.91148598 |
| 48 | nephron tubule formation (GO:0072079) | 4.91144955 |
| 49 | serine family amino acid catabolic process (GO:0009071) | 4.88971347 |
| 50 | glycoside metabolic process (GO:0016137) | 4.88372441 |
| 51 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.87490515 |
| 52 | L-phenylalanine catabolic process (GO:0006559) | 4.87490515 |
| 53 | positive regulation of epidermal growth factor-activated receptor activity (GO:0045741) | 4.83784705 |
| 54 | serine family amino acid metabolic process (GO:0009069) | 4.75974786 |
| 55 | metanephric tubule development (GO:0072170) | 4.75215075 |
| 56 | metanephric nephron tubule development (GO:0072234) | 4.75215075 |
| 57 | valine metabolic process (GO:0006573) | 4.58071366 |
| 58 | activation of transmembrane receptor protein tyrosine kinase activity (GO:0007171) | 4.56066617 |
| 59 | aromatic amino acid family catabolic process (GO:0009074) | 4.56012124 |
| 60 | homocysteine metabolic process (GO:0050667) | 4.55497630 |
| 61 | modified amino acid transport (GO:0072337) | 4.53361615 |
| 62 | amino-acid betaine metabolic process (GO:0006577) | 4.39537244 |
| 63 | metanephric nephron epithelium development (GO:0072243) | 4.37782217 |
| 64 | peptide biosynthetic process (GO:0043043) | 4.32242694 |
| 65 | tryptophan catabolic process (GO:0006569) | 4.30674094 |
| 66 | indole-containing compound catabolic process (GO:0042436) | 4.30674094 |
| 67 | indolalkylamine catabolic process (GO:0046218) | 4.30674094 |
| 68 | fatty acid beta-oxidation (GO:0006635) | 4.28164176 |
| 69 | inositol metabolic process (GO:0006020) | 4.22955324 |
| 70 | fructose metabolic process (GO:0006000) | 4.20729288 |
| 71 | oligosaccharide catabolic process (GO:0009313) | 4.20454279 |
| 72 | peptide catabolic process (GO:0043171) | 4.14931875 |
| 73 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003339 | 4.13891453 |
| 74 | tryptophan metabolic process (GO:0006568) | 4.13677753 |
| 75 | branched-chain amino acid catabolic process (GO:0009083) | 4.12333177 |
| 76 | 2-oxoglutarate metabolic process (GO:0006103) | 4.09741925 |
| 77 | response to parathyroid hormone (GO:0071107) | 4.04241570 |
| 78 | serine family amino acid biosynthetic process (GO:0009070) | 4.03881785 |
| 79 | response to thyroid hormone (GO:0097066) | 4.00467333 |
| 80 | metanephric epithelium development (GO:0072207) | 3.99359975 |
| 81 | fatty acid oxidation (GO:0019395) | 3.96180901 |
| 82 | nephron tubule development (GO:0072080) | 3.93482437 |
| 83 | carnitine metabolic process (GO:0009437) | 3.91876151 |
| 84 | mesenchymal to epithelial transition involved in metanephros morphogenesis (GO:0003337) | 3.90458523 |
| 85 | lipid oxidation (GO:0034440) | 3.88849124 |
| 86 | cellular ketone body metabolic process (GO:0046950) | 3.88640101 |
| 87 | NADH metabolic process (GO:0006734) | 3.86921463 |
| 88 | beta-amyloid metabolic process (GO:0050435) | 3.78748264 |
| 89 | negative regulation of metanephros development (GO:0072217) | 3.78571471 |
| 90 | cellular amino acid catabolic process (GO:0009063) | 3.78179953 |
| 91 | acetyl-CoA metabolic process (GO:0006084) | 3.77557457 |
| 92 | cellular response to ammonium ion (GO:0071242) | 3.77314560 |
| 93 | glutathione metabolic process (GO:0006749) | 3.76433598 |
| 94 | cellular hyperosmotic response (GO:0071474) | 3.75632371 |
| 95 | glomerular visceral epithelial cell development (GO:0072015) | 3.72672640 |
| 96 | response to growth hormone (GO:0060416) | 3.72039990 |
| 97 | glutamate metabolic process (GO:0006536) | 3.68559260 |
| 98 | flavonoid metabolic process (GO:0009812) | 3.68013068 |
| 99 | vitamin transport (GO:0051180) | 3.66142247 |
| 100 | drug metabolic process (GO:0017144) | 3.61977294 |
| 101 | alpha-amino acid catabolic process (GO:1901606) | 3.61741637 |
| 102 | glucuronate metabolic process (GO:0019585) | 3.61597525 |
| 103 | uronic acid metabolic process (GO:0006063) | 3.61597525 |
| 104 | detection of light stimulus involved in visual perception (GO:0050908) | 3.56751648 |
| 105 | detection of light stimulus involved in sensory perception (GO:0050962) | 3.56751648 |
| 106 | fatty acid catabolic process (GO:0009062) | 3.54740709 |
| 107 | regulation of protein localization to cell surface (GO:2000008) | 3.54391241 |
| 108 | response to phenylpropanoid (GO:0080184) | 3.53419993 |
| 109 | indole-containing compound metabolic process (GO:0042430) | 3.53336924 |
| 110 | sulfur amino acid catabolic process (GO:0000098) | 3.51890033 |
| 111 | nephron tubule morphogenesis (GO:0072078) | 3.49473344 |
| 112 | nephron epithelium morphogenesis (GO:0072088) | 3.49473344 |
| 113 | renal tubule development (GO:0061326) | 3.48226580 |
| 114 | response to vitamin A (GO:0033189) | 3.46988803 |
| 115 | N-acetylneuraminate metabolic process (GO:0006054) | 3.46118236 |
| 116 | response to copper ion (GO:0046688) | 3.43762981 |
| 117 | response to magnesium ion (GO:0032026) | 3.43721607 |
| 118 | organic acid catabolic process (GO:0016054) | 3.41994680 |
| 119 | carboxylic acid catabolic process (GO:0046395) | 3.41994680 |
| 120 | glutathione derivative metabolic process (GO:1901685) | 3.39006483 |
| 121 | glutathione derivative biosynthetic process (GO:1901687) | 3.39006483 |
| 122 | aromatic amino acid family metabolic process (GO:0009072) | 3.38836627 |
| 123 | cellular response to vitamin D (GO:0071305) | 3.38437363 |
| 124 | response to lead ion (GO:0010288) | 3.37225120 |
| 125 | monocarboxylic acid catabolic process (GO:0072329) | 3.36144195 |
| 126 | neurotransmitter biosynthetic process (GO:0042136) | 3.34320045 |
| 127 | ketone body metabolic process (GO:1902224) | 3.33766505 |
| 128 | cellular glucuronidation (GO:0052695) | 3.33072667 |
| 129 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 3.32824604 |
| 130 | glutamine family amino acid catabolic process (GO:0009065) | 3.32271441 |
| 131 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 3.32123615 |
| 132 | bone remodeling (GO:0046849) | 3.29719877 |
| 133 | sulfur compound transport (GO:0072348) | 3.29291596 |
| 134 | pattern specification involved in kidney development (GO:0061004) | 3.27327526 |
| 135 | glomerular epithelial cell development (GO:0072310) | 3.26918620 |
| 136 | regulation of metanephric nephron tubule epithelial cell differentiation (GO:0072307) | 3.23970773 |
| 137 | negative regulation of mesenchymal cell apoptotic process (GO:2001054) | 3.22018525 |
| 138 | S-adenosylmethionine metabolic process (GO:0046500) | 3.16606363 |
| 139 | urogenital system development (GO:0001655) | 3.14763419 |
| 140 | positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742) | 3.13246393 |
| 141 | * renal system process (GO:0003014) | 3.12267674 |
| 142 | protein-chromophore linkage (GO:0018298) | 3.07933002 |
| 143 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 3.07273763 |
| 144 | positive regulation of peptidyl-threonine phosphorylation (GO:0010800) | 3.05091195 |
| 145 | potassium ion import (GO:0010107) | 3.02468076 |
| 146 | positive regulation of ERBB signaling pathway (GO:1901186) | 2.98466101 |
| 147 | sodium ion export (GO:0071436) | 2.97732131 |
| 148 | behavioral response to nicotine (GO:0035095) | 2.97690526 |
| 149 | response to salt stress (GO:0009651) | 2.96786293 |
| 150 | ERK1 and ERK2 cascade (GO:0070371) | 2.94196111 |
| 151 | inorganic anion transport (GO:0015698) | 2.90721835 |
| 152 | chloride transmembrane transport (GO:1902476) | 2.90179617 |
| 153 | cellular sodium ion homeostasis (GO:0006883) | 2.87309457 |
| 154 | regulation of fever generation (GO:0031620) | 2.86142003 |
| 155 | microglial cell activation (GO:0001774) | 2.84460842 |
| 156 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 2.84176120 |
| 157 | regulation of anion transport (GO:0044070) | 2.83877773 |
| 158 | positive regulation of heat generation (GO:0031652) | 2.83858291 |
| 159 | cellular potassium ion homeostasis (GO:0030007) | 2.83102060 |
| 160 | regulation of cholesterol efflux (GO:0010874) | 2.82295743 |
| 161 | sodium ion transport (GO:0006814) | 2.81055352 |
| 162 | mammary gland alveolus development (GO:0060749) | 2.80607943 |
| 163 | regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic process (GO:2 | 2.80503477 |
| 164 | metanephric mesenchyme development (GO:0072075) | 2.76981025 |
| 165 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 2.76462814 |
| 166 | fat-soluble vitamin metabolic process (GO:0006775) | 2.75424246 |
| 167 | inorganic anion transmembrane transport (GO:0098661) | 2.73487007 |
| 168 | chloride transport (GO:0006821) | 2.73295699 |
| 169 | sodium ion homeostasis (GO:0055078) | 2.72706306 |
| 170 | kidney epithelium development (GO:0072073) | 2.69900044 |
| 171 | L-methionine salvage (GO:0071267) | 2.69787374 |
| 172 | L-methionine biosynthetic process (GO:0071265) | 2.69787374 |
| 173 | amino acid salvage (GO:0043102) | 2.69787374 |
| 174 | aminoglycoside antibiotic metabolic process (GO:0030647) | 11.2421272 |
| 175 | drug transmembrane transport (GO:0006855) | 11.0233752 |
| 176 | urate metabolic process (GO:0046415) | 10.9983908 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 5.89971404 |
| 2 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.26676460 |
| 3 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 4.44223866 |
| 4 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.06803771 |
| 5 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 3.70738731 |
| 6 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 3.65247669 |
| 7 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.01957549 |
| 8 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.79627715 |
| 9 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.74472020 |
| 10 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.66569194 |
| 11 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 2.59325815 |
| 12 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 2.48267342 |
| 13 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.41116721 |
| 14 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.39686808 |
| 15 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.37975515 |
| 16 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.35587406 |
| 17 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.34341408 |
| 18 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.26741592 |
| 19 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.20473532 |
| 20 | AR_21909140_ChIP-Seq_LNCAP_Human | 2.16842852 |
| 21 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.15596305 |
| 22 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.12940943 |
| 23 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.04603328 |
| 24 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 2.03706306 |
| 25 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.97990513 |
| 26 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.97361368 |
| 27 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.88214900 |
| 28 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.87558258 |
| 29 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.87390009 |
| 30 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.86026075 |
| 31 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.85491271 |
| 32 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.83957943 |
| 33 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.83377508 |
| 34 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.81583785 |
| 35 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.79003303 |
| 36 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.78520442 |
| 37 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.78520442 |
| 38 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.78257666 |
| 39 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.78130148 |
| 40 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.77889373 |
| 41 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.70124057 |
| 42 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.69702631 |
| 43 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.67946492 |
| 44 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.67565031 |
| 45 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.64585545 |
| 46 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.64517272 |
| 47 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.60870147 |
| 48 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.56359228 |
| 49 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.53165428 |
| 50 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.47974179 |
| 51 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.46776935 |
| 52 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.45610376 |
| 53 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.42834426 |
| 54 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.42106833 |
| 55 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.40647282 |
| 56 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.40628522 |
| 57 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.38600813 |
| 58 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.36223996 |
| 59 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.35883061 |
| 60 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.34899044 |
| 61 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.33424764 |
| 62 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.31248740 |
| 63 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.30763913 |
| 64 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.30706553 |
| 65 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.30379160 |
| 66 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.30118413 |
| 67 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.29902934 |
| 68 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.28361600 |
| 69 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.27642210 |
| 70 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.26781880 |
| 71 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 1.26435271 |
| 72 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.25282142 |
| 73 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.24688139 |
| 74 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.24656400 |
| 75 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.22448773 |
| 76 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.22396741 |
| 77 | VDR_22108803_ChIP-Seq_LS180_Human | 1.22110648 |
| 78 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.21579071 |
| 79 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.20969001 |
| 80 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.20304415 |
| 81 | RXR_22108803_ChIP-Seq_LS180_Human | 1.18874020 |
| 82 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.18716204 |
| 83 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.18560036 |
| 84 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.18560036 |
| 85 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.15313186 |
| 86 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.13575660 |
| 87 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.13561201 |
| 88 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.13561201 |
| 89 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.12286848 |
| 90 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.11941347 |
| 91 | OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.11752914 |
| 92 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.11511941 |
| 93 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.10299065 |
| 94 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.09845881 |
| 95 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.09259884 |
| 96 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 1.06793319 |
| 97 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.06791080 |
| 98 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.04796316 |
| 99 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 1.04499395 |
| 100 | KDM2B_26808549_Chip-Seq_REH_Human | 1.03851620 |
| 101 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.03036595 |
| 102 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.03000470 |
| 103 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.02597132 |
| 104 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.01981943 |
| 105 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.01976814 |
| 106 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.01465701 |
| 107 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.01445033 |
| 108 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.01249458 |
| 109 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.00731700 |
| 110 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.00523938 |
| 111 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.00195882 |
| 112 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.99255794 |
| 113 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.99104735 |
| 114 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.98997168 |
| 115 | TCF4_23295773_ChIP-Seq_U87_Human | 0.98627868 |
| 116 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.97106169 |
| 117 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.96188580 |
| 118 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.95207014 |
| 119 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 0.94884142 |
| 120 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 0.93851675 |
| 121 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.93746834 |
| 122 | P300_19829295_ChIP-Seq_ESCs_Human | 0.93482875 |
| 123 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.93086332 |
| 124 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.92988848 |
| 125 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.92923666 |
| 126 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.92383468 |
| 127 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.91892253 |
| 128 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.91626688 |
| 129 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.91529052 |
| 130 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.91511112 |
| 131 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.91416957 |
| 132 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 0.90977793 |
| 133 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.90586250 |
| 134 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.90505502 |
| 135 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.89981459 |
| 136 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.89610465 |
| 137 | ZFX_18555785_Chip-Seq_ESCs_Mouse | 0.89339897 |
| 138 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.89310007 |
| 139 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.88987998 |
| 140 | * CBP_21632823_ChIP-Seq_H3396_Human | 0.88834332 |
| 141 | STAT3_23295773_ChIP-Seq_U87_Human | 0.88811938 |
| 142 | CJUN_26792858_Chip-Seq_BT549_Human | 0.88769764 |
| 143 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.88702766 |
| 144 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.88684930 |
| 145 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.87244501 |
| 146 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.86825426 |
| 147 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.85458931 |
| 148 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.85269120 |
| 149 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.83883984 |
| 150 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.83534162 |
| 151 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.83270851 |
| 152 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.82287691 |
| 153 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.81741845 |
| 154 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 0.81248229 |
| 155 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.80853108 |
| 156 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.78831703 |
| 157 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.77730917 |
| 158 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.74913544 |
| 159 | NANOG_18692474_ChIP-Seq_MEFs_Mouse | 0.74671509 |
| 160 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.74340028 |
| 161 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.74249446 |
| 162 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.73570050 |
| 163 | P63_20808887_ChIP-Seq_KERATINOCYTES_Human | 0.73142372 |
| 164 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.72844580 |
| 165 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.72498156 |
| 166 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.72207052 |
| 167 | P68_20966046_ChIP-Seq_HELA_Human | 0.71803969 |
| 168 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.70628718 |
| 169 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.70264850 |
| 170 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.69910436 |
| 171 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.69875765 |
| 172 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.69627118 |
| 173 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 0.69586088 |
| 174 | GATA2_19941826_ChIP-Seq_K562_Human | 0.69296888 |
| 175 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.68615729 |
| 176 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 0.68331603 |
| 177 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.66082263 |
| 178 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.66045980 |
| 179 | MITF_21258399_ChIP-Seq_MELANOMA_Human | 0.65851815 |
| 180 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.64693424 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 7.68215697 |
| 2 | MP0004043_abnormal_pH_regulation | 6.22645575 |
| 3 | MP0003011_delayed_dark_adaptation | 6.13335467 |
| 4 | MP0002139_abnormal_hepatobiliary_system | 5.20820771 |
| 5 | MP0004019_abnormal_vitamin_homeostasis | 5.09498598 |
| 6 | MP0005332_abnormal_amino_acid | 4.97464319 |
| 7 | MP0002138_abnormal_hepatobiliary_system | 4.21096787 |
| 8 | MP0001765_abnormal_ion_homeostasis | 3.84060603 |
| 9 | * MP0009643_abnormal_urine_homeostasis | 3.75296446 |
| 10 | MP0003195_calcinosis | 3.66658522 |
| 11 | MP0005636_abnormal_mineral_homeostasis | 3.16625116 |
| 12 | MP0008875_abnormal_xenobiotic_pharmacok | 3.03600743 |
| 13 | MP0005377_hearing/vestibular/ear_phenot | 2.95321128 |
| 14 | MP0003878_abnormal_ear_physiology | 2.95321128 |
| 15 | MP0001756_abnormal_urination | 2.85410459 |
| 16 | MP0001958_emphysema | 2.84142237 |
| 17 | * MP0002136_abnormal_kidney_physiology | 2.76225294 |
| 18 | MP0003252_abnormal_bile_duct | 2.47709695 |
| 19 | MP0005058_abnormal_lysosome_morphology | 2.39486391 |
| 20 | MP0005365_abnormal_bile_salt | 2.32547930 |
| 21 | MP0005085_abnormal_gallbladder_physiolo | 2.26747659 |
| 22 | MP0003183_abnormal_peptide_metabolism | 1.84901371 |
| 23 | MP0003186_abnormal_redox_activity | 1.79543446 |
| 24 | MP0004885_abnormal_endolymph | 1.75250654 |
| 25 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.71864760 |
| 26 | MP0005083_abnormal_biliary_tract | 1.71815351 |
| 27 | MP0000538_abnormal_urinary_bladder | 1.58447251 |
| 28 | MP0001270_distended_abdomen | 1.58316230 |
| 29 | MP0005084_abnormal_gallbladder_morpholo | 1.58283571 |
| 30 | MP0000534_abnormal_ureter_morphology | 1.53509229 |
| 31 | MP0008961_abnormal_basal_metabolism | 1.48437028 |
| 32 | MP0005319_abnormal_enzyme/_coenzyme | 1.42433225 |
| 33 | MP0003806_abnormal_nucleotide_metabolis | 1.41015866 |
| 34 | MP0005551_abnormal_eye_electrophysiolog | 1.39360147 |
| 35 | MP0005423_abnormal_somatic_nervous | 1.37611871 |
| 36 | MP0003300_gastrointestinal_ulcer | 1.37464054 |
| 37 | MP0001986_abnormal_taste_sensitivity | 1.35871059 |
| 38 | MP0002928_abnormal_bile_duct | 1.34191077 |
| 39 | MP0005253_abnormal_eye_physiology | 1.31366306 |
| 40 | MP0002168_other_aberrant_phenotype | 1.25063925 |
| 41 | MP0005451_abnormal_body_composition | 1.21837546 |
| 42 | MP0006036_abnormal_mitochondrial_physio | 1.20905920 |
| 43 | MP0002876_abnormal_thyroid_physiology | 1.18875098 |
| 44 | MP0005670_abnormal_white_adipose | 1.13121315 |
| 45 | MP0002089_abnormal_postnatal_growth/wei | 1.12395111 |
| 46 | MP0000230_abnormal_systemic_arterial | 1.11196059 |
| 47 | MP0004147_increased_porphyrin_level | 1.09031335 |
| 48 | MP0003172_abnormal_lysosome_physiology | 1.08057646 |
| 49 | MP0002896_abnormal_bone_mineralization | 1.06347269 |
| 50 | MP0002135_abnormal_kidney_morphology | 1.05045319 |
| 51 | MP0005535_abnormal_body_temperature | 1.03366264 |
| 52 | MP0008872_abnormal_physiological_respon | 1.02972854 |
| 53 | MP0005666_abnormal_adipose_tissue | 1.02525288 |
| 54 | MP0003283_abnormal_digestive_organ | 0.90870331 |
| 55 | MP0004264_abnormal_extraembryonic_tissu | 0.89556881 |
| 56 | MP0002118_abnormal_lipid_homeostasis | 0.89136969 |
| 57 | MP0001764_abnormal_homeostasis | 0.88415535 |
| 58 | MP0001666_abnormal_nutrient_absorption | 0.87148467 |
| 59 | MP0000747_muscle_weakness | 0.83557360 |
| 60 | MP0001502_abnormal_circadian_rhythm | 0.82830237 |
| 61 | MP0001968_abnormal_touch/_nociception | 0.78601166 |
| 62 | MP0003638_abnormal_response/metabolism_ | 0.78475565 |
| 63 | MP0002272_abnormal_nervous_system | 0.78332085 |
| 64 | MP0003646_muscle_fatigue | 0.78066403 |
| 65 | MP0009642_abnormal_blood_homeostasis | 0.75958553 |
| 66 | MP0003191_abnormal_cellular_cholesterol | 0.75152917 |
| 67 | MP0009764_decreased_sensitivity_to | 0.70369181 |
| 68 | MP0000371_diluted_coat_color | 0.68682557 |
| 69 | MP0001485_abnormal_pinna_reflex | 0.68089347 |
| 70 | MP0002796_impaired_skin_barrier | 0.66014919 |
| 71 | MP0010234_abnormal_vibrissa_follicle | 0.66013808 |
| 72 | MP0003879_abnormal_hair_cell | 0.65339197 |
| 73 | MP0001661_extended_life_span | 0.64541470 |
| 74 | MP0003329_amyloid_beta_deposits | 0.64191169 |
| 75 | MP0001324_abnormal_eye_pigmentation | 0.63312298 |
| 76 | MP0000609_abnormal_liver_physiology | 0.62924134 |
| 77 | MP0003690_abnormal_glial_cell | 0.62819542 |
| 78 | MP0008569_lethality_at_weaning | 0.62192879 |
| 79 | MP0005220_abnormal_exocrine_pancreas | 0.62180328 |
| 80 | MP0009046_muscle_twitch | 0.60599106 |
| 81 | MP0001501_abnormal_sleep_pattern | 0.59420227 |
| 82 | MP0010329_abnormal_lipoprotein_level | 0.59397348 |
| 83 | MP0003136_yellow_coat_color | 0.59262893 |
| 84 | MP0001486_abnormal_startle_reflex | 0.59087347 |
| 85 | MP0002115_abnormal_skeleton_extremities | 0.58363618 |
| 86 | MP0005395_other_phenotype | 0.57815850 |
| 87 | MP0002064_seizures | 0.57544742 |
| 88 | MP0000678_abnormal_parathyroid_gland | 0.56804221 |
| 89 | MP0004858_abnormal_nervous_system | 0.55492698 |
| 90 | MP0000026_abnormal_inner_ear | 0.55205616 |
| 91 | MP0000598_abnormal_liver_morphology | 0.55034303 |
| 92 | MP0002229_neurodegeneration | 0.54141003 |
| 93 | MP0008469_abnormal_protein_level | 0.53309812 |
| 94 | MP0005501_abnormal_skin_physiology | 0.52876465 |
| 95 | MP0002736_abnormal_nociception_after | 0.50974238 |
| 96 | MP0002998_abnormal_bone_remodeling | 0.49641267 |
| 97 | MP0005167_abnormal_blood-brain_barrier | 0.49617602 |
| 98 | MP0005386_behavior/neurological_phenoty | 0.49139134 |
| 99 | MP0004924_abnormal_behavior | 0.49139134 |
| 100 | MP0004742_abnormal_vestibular_system | 0.49078152 |
| 101 | MP0003938_abnormal_ear_development | 0.47642585 |
| 102 | MP0009745_abnormal_behavioral_response | 0.47362168 |
| 103 | MP0005165_increased_susceptibility_to | 0.47186074 |
| 104 | MP0010368_abnormal_lymphatic_system | 0.47077461 |
| 105 | MP0003635_abnormal_synaptic_transmissio | 0.46843952 |
| 106 | MP0000631_abnormal_neuroendocrine_gland | 0.46763429 |
| 107 | MP0003045_fibrosis | 0.46651660 |
| 108 | MP0002078_abnormal_glucose_homeostasis | 0.46583807 |
| 109 | MP0003953_abnormal_hormone_level | 0.46481250 |
| 110 | MP0006035_abnormal_mitochondrial_morpho | 0.45490751 |
| 111 | MP0003795_abnormal_bone_structure | 0.45389465 |
| 112 | MP0001970_abnormal_pain_threshold | 0.44625405 |
| 113 | MP0005408_hypopigmentation | 0.44531765 |
| 114 | MP0002063_abnormal_learning/memory/cond | 0.44321179 |
| 115 | MP0005375_adipose_tissue_phenotype | 0.43848654 |
| 116 | MP0000163_abnormal_cartilage_morphology | 0.43424614 |
| 117 | MP0002069_abnormal_eating/drinking_beha | 0.43087085 |
| 118 | MP0003959_abnormal_lean_body | 0.42272418 |
| 119 | MP0002067_abnormal_sensory_capabilities | 0.40627905 |
| 120 | MP0005391_vision/eye_phenotype | 0.40381583 |
| 121 | MP0004859_abnormal_synaptic_plasticity | 0.39492365 |
| 122 | MP0001944_abnormal_pancreas_morphology | 0.39001567 |
| 123 | MP0001663_abnormal_digestive_system | 0.38857298 |
| 124 | MP0009672_abnormal_birth_weight | 0.38503011 |
| 125 | MP0004272_abnormal_basement_membrane | 0.38412999 |
| 126 | MP0002735_abnormal_chemical_nociception | 0.38060015 |
| 127 | MP0002734_abnormal_mechanical_nocicepti | 0.37452633 |
| 128 | MP0001346_abnormal_lacrimal_gland | 0.36694568 |
| 129 | MP0009780_abnormal_chondrocyte_physiolo | 0.35418035 |
| 130 | MP0001963_abnormal_hearing_physiology | 0.35004156 |
| 131 | MP0002572_abnormal_emotion/affect_behav | 0.34908914 |
| 132 | MP0003631_nervous_system_phenotype | 0.34908587 |
| 133 | MP0004130_abnormal_muscle_cell | 0.34509821 |
| 134 | MP0005195_abnormal_posterior_eye | 0.34430757 |
| 135 | MP0004484_altered_response_of | 0.34355080 |
| 136 | MP0002098_abnormal_vibrissa_morphology | 0.34274033 |
| 137 | MP0009115_abnormal_fat_cell | 0.34191831 |
| 138 | MP0005646_abnormal_pituitary_gland | 0.33673617 |
| 139 | MP0001731_abnormal_postnatal_growth | 0.33545412 |
| 140 | MP0001177_atelectasis | 0.33500369 |
| 141 | MP0003123_paternal_imprinting | 0.33301748 |
| 142 | MP0000003_abnormal_adipose_tissue | 0.33075472 |
| 143 | MP0000920_abnormal_myelination | 0.32456333 |
| 144 | MP0003633_abnormal_nervous_system | 0.31676881 |
| 145 | MP0010386_abnormal_urinary_bladder | 0.31337276 |
| 146 | MP0003221_abnormal_cardiomyocyte_apopto | 0.29363576 |
| 147 | MP0003075_altered_response_to | 0.28916029 |
| 148 | MP0002113_abnormal_skeleton_development | 0.28738359 |
| 149 | MP0002971_abnormal_brown_adipose | 0.28391711 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Increased circulating renin level (HP:0000848) | 7.40259213 |
| 2 | Hypokalemic alkalosis (HP:0001949) | 6.89439717 |
| 3 | Gout (HP:0001997) | 6.85292875 |
| 4 | Metabolic alkalosis (HP:0200114) | 6.83048879 |
| 5 | Hypomagnesemia (HP:0002917) | 6.38569829 |
| 6 | Polyuria (HP:0000103) | 6.36006609 |
| 7 | Hyperactive renin-angiotensin system (HP:0000841) | 6.32614615 |
| 8 | Abnormal urine output (HP:0012590) | 5.95263085 |
| 9 | Abnormality of chloride homeostasis (HP:0011422) | 5.92415675 |
| 10 | Abnormality of renal excretion (HP:0011036) | 5.79937451 |
| 11 | Proximal tubulopathy (HP:0000114) | 5.66801215 |
| 12 | Abnormality of magnesium homeostasis (HP:0004921) | 5.40678105 |
| 13 | Abnormal drinking behavior (HP:0030082) | 5.12110842 |
| 14 | Polydipsia (HP:0001959) | 5.12110842 |
| 15 | Increased purine levels (HP:0004368) | 4.81950682 |
| 16 | Hyperuricemia (HP:0002149) | 4.81950682 |
| 17 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.71145420 |
| 18 | Hyperglycinuria (HP:0003108) | 4.60262860 |
| 19 | Alkalosis (HP:0001948) | 4.57187770 |
| 20 | Abnormality of renin-angiotensin system (HP:0000847) | 4.55095528 |
| 21 | Abnormality of purine metabolism (HP:0004352) | 4.50622309 |
| 22 | Generalized aminoaciduria (HP:0002909) | 4.48224571 |
| 23 | Renal salt wasting (HP:0000127) | 4.39249792 |
| 24 | Hyperaldosteronism (HP:0000859) | 4.32450910 |
| 25 | Tetany (HP:0001281) | 4.28229564 |
| 26 | Hypercalciuria (HP:0002150) | 4.13879032 |
| 27 | Abnormality of urine glucose concentration (HP:0011016) | 3.89922725 |
| 28 | Glycosuria (HP:0003076) | 3.89922725 |
| 29 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.80283425 |
| 30 | Abnormality of glycine metabolism (HP:0010895) | 3.80283425 |
| 31 | Renal tubular acidosis (HP:0001947) | 3.57001040 |
| 32 | Ketoacidosis (HP:0001993) | 3.56152166 |
| 33 | Large eyes (HP:0001090) | 3.49027232 |
| 34 | Hyperphosphaturia (HP:0003109) | 3.47726579 |
| 35 | Hypokalemia (HP:0002900) | 3.47348210 |
| 36 | Delayed epiphyseal ossification (HP:0002663) | 3.44082894 |
| 37 | Abnormality of nucleobase metabolism (HP:0010932) | 3.34044852 |
| 38 | Abnormal urine phosphate concentration (HP:0012599) | 3.27692541 |
| 39 | Ketosis (HP:0001946) | 3.26106566 |
| 40 | Hydroxyprolinuria (HP:0003080) | 3.17954583 |
| 41 | Abnormality of proline metabolism (HP:0010907) | 3.17954583 |
| 42 | Nephrocalcinosis (HP:0000121) | 3.04472462 |
| 43 | Abnormality of potassium homeostasis (HP:0011042) | 2.94507567 |
| 44 | Nephrolithiasis (HP:0000787) | 2.93128478 |
| 45 | Vascular calcification (HP:0004934) | 2.92564337 |
| 46 | Hypophosphatemia (HP:0002148) | 2.92186989 |
| 47 | Metaphyseal cupping (HP:0003021) | 2.78721730 |
| 48 | Rickets (HP:0002748) | 2.78070452 |
| 49 | Vacuolated lymphocytes (HP:0001922) | 2.76607608 |
| 50 | Generalized muscle weakness (HP:0003324) | 2.76124884 |
| 51 | Delayed CNS myelination (HP:0002188) | 2.71929151 |
| 52 | Hyperglycinemia (HP:0002154) | 2.67278316 |
| 53 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.67064544 |
| 54 | Cardiovascular calcification (HP:0011915) | 2.61485896 |
| 55 | Widely patent fontanelles and sutures (HP:0004492) | 2.59119829 |
| 56 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.54080263 |
| 57 | Abnormal enzyme/coenzyme activity (HP:0012379) | 2.44598416 |
| 58 | Hyperammonemia (HP:0001987) | 2.43438937 |
| 59 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 2.41233264 |
| 60 | Dicarboxylic aciduria (HP:0003215) | 2.41233264 |
| 61 | Abnormality of renal resorption (HP:0011038) | 2.40093161 |
| 62 | Confusion (HP:0001289) | 2.39166591 |
| 63 | Dehydration (HP:0001944) | 2.38793402 |
| 64 | Abnormality of alkaline phosphatase activity (HP:0004379) | 2.37948119 |
| 65 | Thin bony cortex (HP:0002753) | 2.36021442 |
| 66 | Enlarged kidneys (HP:0000105) | 2.31650677 |
| 67 | Hypotension (HP:0002615) | 2.30635099 |
| 68 | Abnormality of Sharpey fibers (HP:0100685) | 2.26035491 |
| 69 | Hyponatremia (HP:0002902) | 2.25008335 |
| 70 | Vomiting (HP:0002013) | 2.24347884 |
| 71 | Malnutrition (HP:0004395) | 2.23869188 |
| 72 | Abnormality of sodium homeostasis (HP:0010931) | 2.23595704 |
| 73 | Metabolic acidosis (HP:0001942) | 2.22663985 |
| 74 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.21582423 |
| 75 | Methylmalonic aciduria (HP:0012120) | 2.19105977 |
| 76 | Abnormal tarsal ossification (HP:0008369) | 2.18154114 |
| 77 | Renal tubular dysfunction (HP:0000124) | 2.18105830 |
| 78 | Bilateral sensorineural hearing impairment (HP:0008619) | 2.08735562 |
| 79 | Lymphangioma (HP:0100764) | 2.03919093 |
| 80 | Lethargy (HP:0001254) | 2.02853828 |
| 81 | Sensorimotor neuropathy (HP:0007141) | 2.02093504 |
| 82 | Abnormality of the costochondral junction (HP:0000919) | 2.01223384 |
| 83 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.98809387 |
| 84 | Adrenal overactivity (HP:0002717) | 1.96738660 |
| 85 | Bicornuate uterus (HP:0000813) | 1.95537722 |
| 86 | Metaphyseal irregularity (HP:0003025) | 1.93791459 |
| 87 | Tubulointerstitial fibrosis (HP:0005576) | 1.93205126 |
| 88 | Elevated alkaline phosphatase (HP:0003155) | 1.90932647 |
| 89 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.88642102 |
| 90 | Potter facies (HP:0002009) | 1.87586278 |
| 91 | Facial shape deformation (HP:0011334) | 1.87586278 |
| 92 | Irritability (HP:0000737) | 1.86118722 |
| 93 | Metaphyseal dysplasia (HP:0100255) | 1.84506577 |
| 94 | Chondrocalcinosis (HP:0000934) | 1.78280571 |
| 95 | Nausea (HP:0002018) | 1.77451068 |
| 96 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.75697053 |
| 97 | Late onset (HP:0003584) | 1.73364673 |
| 98 | Tubular atrophy (HP:0000092) | 1.73349392 |
| 99 | Neonatal onset (HP:0003623) | 1.71783449 |
| 100 | Abnormality of carpal bone ossification (HP:0006257) | 1.70958473 |
| 101 | Tachypnea (HP:0002789) | 1.70949443 |
| 102 | Decreased circulating renin level (HP:0003351) | 1.70134991 |
| 103 | Glomerulosclerosis (HP:0000096) | 1.69869012 |
| 104 | Abnormality of serum amino acid levels (HP:0003112) | 1.68449746 |
| 105 | Dysostosis multiplex (HP:0000943) | 1.66873636 |
| 106 | Decreased central vision (HP:0007663) | 1.57016628 |
| 107 | Abnormality of the renal medulla (HP:0100957) | 1.56492252 |
| 108 | Action tremor (HP:0002345) | 1.53548909 |
| 109 | Scotoma (HP:0000575) | 1.53267427 |
| 110 | Nephrogenic diabetes insipidus (HP:0009806) | 1.50202258 |
| 111 | Attenuation of retinal blood vessels (HP:0007843) | 1.43659556 |
| 112 | Paresthesia (HP:0003401) | 1.40903623 |
| 113 | Hyperkalemia (HP:0002153) | 1.38352200 |
| 114 | Choroideremia (HP:0001139) | 1.36822168 |
| 115 | Premature birth (HP:0001622) | 1.29091335 |
| 116 | Focal segmental glomerulosclerosis (HP:0000097) | 1.28853777 |
| 117 | Ulnar claw (HP:0001178) | 1.28836173 |
| 118 | Abnormal platelet function (HP:0011869) | 1.28229406 |
| 119 | Impaired platelet aggregation (HP:0003540) | 1.28229406 |
| 120 | Congenital stationary night blindness (HP:0007642) | 1.27443347 |
| 121 | Abnormality of macular pigmentation (HP:0008002) | 1.23253636 |
| 122 | Macular degeneration (HP:0000608) | 1.20543898 |
| 123 | Osteopenia (HP:0000938) | 1.15201260 |
| 124 | Abnormality of the fovea (HP:0000493) | 1.14808299 |
| 125 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 1.10423275 |
| 126 | Abnormality of alanine metabolism (HP:0010916) | 1.10423275 |
| 127 | Hyperalaninemia (HP:0003348) | 1.10423275 |
| 128 | Tubulointerstitial abnormality (HP:0001969) | 1.10245304 |
| 129 | Dysdiadochokinesis (HP:0002075) | 1.06264109 |
| 130 | Peripheral hypomyelination (HP:0007182) | 1.05699153 |
| 131 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.00924763 |
| 132 | Intellectual disability, moderate (HP:0002342) | 1.00530109 |
| 133 | Hypothermia (HP:0002045) | 0.99716750 |
| 134 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 0.99022006 |
| 135 | Segmental peripheral demyelination/remyelination (HP:0003481) | 0.97722683 |
| 136 | Abnormality of the renal cortex (HP:0011035) | 0.91704571 |
| 137 | Thyroid-stimulating hormone excess (HP:0002925) | 0.88778438 |
| 138 | Chorioretinal atrophy (HP:0000533) | 0.88049515 |
| 139 | Enlarged epiphyses (HP:0010580) | 0.85234343 |
| 140 | Abnormal eating behavior (HP:0100738) | 0.84907100 |
| 141 | Abnormal rod and cone electroretinograms (HP:0008323) | 0.84149770 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | WNK4 | 9.53139006 |
| 2 | OXSR1 | 7.13321921 |
| 3 | WNK3 | 7.11249194 |
| 4 | STK39 | 4.59610136 |
| 5 | BCKDK | 3.37732416 |
| 6 | STK38L | 2.62689092 |
| 7 | NEK1 | 2.19161084 |
| 8 | WNK1 | 2.16040054 |
| 9 | PDK3 | 2.10068116 |
| 10 | PDK4 | 2.10068116 |
| 11 | CCNB1 | 1.90034603 |
| 12 | SGK223 | 1.86882228 |
| 13 | SGK494 | 1.86882228 |
| 14 | STK38 | 1.54878034 |
| 15 | PDK2 | 1.38695011 |
| 16 | CAMKK2 | 1.34299996 |
| 17 | NEK2 | 1.28703874 |
| 18 | MST1R | 1.23517966 |
| 19 | MST4 | 1.14180119 |
| 20 | FGFR4 | 1.09936137 |
| 21 | GRK1 | 1.03468917 |
| 22 | LRRK2 | 1.03377316 |
| 23 | EPHB1 | 0.95894121 |
| 24 | GRK6 | 0.92992449 |
| 25 | SGK3 | 0.92606076 |
| 26 | CAMK1D | 0.90524157 |
| 27 | PINK1 | 0.90182512 |
| 28 | SGK2 | 0.88642279 |
| 29 | GSK3A | 0.81117128 |
| 30 | TAF1 | 0.75476038 |
| 31 | DYRK1B | 0.73651570 |
| 32 | NTRK3 | 0.72140892 |
| 33 | MAP3K7 | 0.67097090 |
| 34 | SGK1 | 0.64534482 |
| 35 | CAMKK1 | 0.63820352 |
| 36 | PTK2 | 0.62857150 |
| 37 | PAK4 | 0.55937503 |
| 38 | ABL2 | 0.52194714 |
| 39 | PTK6 | 0.50487293 |
| 40 | MAP3K3 | 0.50351092 |
| 41 | TGFBR2 | 0.50346689 |
| 42 | MAPK11 | 0.49100242 |
| 43 | TIE1 | 0.48668011 |
| 44 | PRKAA1 | 0.47170232 |
| 45 | PDPK1 | 0.47049515 |
| 46 | ERN1 | 0.46693037 |
| 47 | TRIB3 | 0.46344759 |
| 48 | SMG1 | 0.46180602 |
| 49 | AKT3 | 0.43731357 |
| 50 | PAK3 | 0.41620670 |
| 51 | INSRR | 0.39081521 |
| 52 | PRKCI | 0.37412252 |
| 53 | PTK2B | 0.37341752 |
| 54 | PRKAA2 | 0.36430638 |
| 55 | STK11 | 0.35599364 |
| 56 | MET | 0.35141072 |
| 57 | FER | 0.35065565 |
| 58 | PRKD2 | 0.34528413 |
| 59 | PRKCZ | 0.33431165 |
| 60 | PDK1 | 0.32756146 |
| 61 | STK10 | 0.32707022 |
| 62 | NTRK1 | 0.31706071 |
| 63 | CAMK1 | 0.30624024 |
| 64 | RIPK1 | 0.30533811 |
| 65 | TNIK | 0.29451659 |
| 66 | YES1 | 0.26919648 |
| 67 | UHMK1 | 0.26071120 |
| 68 | MINK1 | 0.25800663 |
| 69 | TGFBR1 | 0.25440767 |
| 70 | MAP3K2 | 0.24508975 |
| 71 | IRAK2 | 0.23682202 |
| 72 | EPHA4 | 0.23662797 |
| 73 | ADRBK2 | 0.23434982 |
| 74 | CSNK1A1 | 0.22434988 |
| 75 | ADRBK1 | 0.22269609 |
| 76 | HIPK2 | 0.22176656 |
| 77 | CHUK | 0.22072677 |
| 78 | PRKCH | 0.21990534 |
| 79 | PRKCD | 0.21749196 |
| 80 | FRK | 0.21562975 |
| 81 | GRK5 | 0.21282226 |
| 82 | PRKACG | 0.20930743 |
| 83 | ERBB4 | 0.19373518 |
| 84 | MAPKAPK5 | 0.19098271 |
| 85 | PAK6 | 0.19005492 |
| 86 | BLK | 0.18849920 |
| 87 | MYLK | 0.18522660 |
| 88 | PNCK | 0.18479865 |
| 89 | BMX | 0.16897941 |
| 90 | KSR2 | 0.16558856 |
| 91 | MAP2K4 | 0.16524258 |
| 92 | IRAK3 | 0.15698905 |
| 93 | PRKCA | 0.14903426 |
| 94 | CSF1R | 0.14838763 |
| 95 | AKT2 | 0.14483831 |
| 96 | SYK | 0.14340016 |
| 97 | NME2 | 0.14322719 |
| 98 | CAMK1G | 0.13971654 |
| 99 | PRKCG | 0.13799414 |
| 100 | MAPK15 | 0.13753891 |
| 101 | LATS1 | 0.13464289 |
| 102 | FGR | 0.13081847 |
| 103 | ERBB2 | 0.12668911 |
| 104 | ROCK1 | 0.12269736 |
| 105 | PDGFRB | 0.12079509 |
| 106 | MAP3K14 | 0.11982265 |
| 107 | PRKACA | 0.11788920 |
| 108 | VRK2 | 0.10981085 |
| 109 | MAP2K6 | 0.10496605 |
| 110 | BMPR1B | 0.10464848 |
| 111 | PRKG1 | 0.10391301 |
| 112 | MARK1 | 0.09828265 |
| 113 | PIM1 | 0.09660636 |
| 114 | JAK2 | 0.09458945 |
| 115 | PRKCE | 0.09440744 |
| 116 | INSR | 0.08743502 |
| 117 | MAPK12 | 0.08628726 |
| 118 | PRKD3 | 0.08441518 |
| 119 | TRPM7 | 0.08390570 |
| 120 | SCYL2 | 0.08138726 |
| 121 | PHKG1 | 0.07467756 |
| 122 | PHKG2 | 0.07467756 |
| 123 | IRAK1 | 0.07308823 |
| 124 | RET | 0.07095825 |
| 125 | CAMK2A | 0.06728205 |
| 126 | MAP2K1 | 0.06391375 |
| 127 | CAMK4 | 0.06348661 |
| 128 | CAMK2B | 0.06297229 |
| 129 | ZAP70 | 0.06223821 |
| 130 | MAP2K3 | 0.06211882 |
| 131 | KIT | 0.05795684 |
| 132 | MARK2 | 0.05658338 |
| 133 | SRC | 0.05358711 |
| 134 | MUSK | 0.05180679 |
| 135 | MAPK13 | 0.04537704 |
| 136 | DYRK1A | 0.03971609 |
| 137 | PRKCB | 0.03755039 |
| 138 | TAOK1 | 0.03122456 |
| 139 | FES | 0.02980587 |
| 140 | MTOR | 0.02751181 |
| 141 | DAPK2 | 0.02693748 |
| 142 | RPS6KA3 | 0.02332982 |
| 143 | NME1 | 0.02232004 |
| 144 | PRKCQ | 0.02089759 |
| 145 | CSK | 0.02040552 |
| 146 | MAPK4 | 0.01908328 |
| 147 | ROCK2 | 0.01686537 |
| 148 | PRKACB | 0.01415130 |
| 149 | CDK5 | 0.01115775 |
| 150 | MAP3K11 | 0.01014488 |
| 151 | PDGFRA | -0.0093595 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 4.08681178 |
| 2 | Butanoate metabolism_Homo sapiens_hsa00650 | 3.82894577 |
| 3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.55881747 |
| 4 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 3.50884215 |
| 5 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 3.39871300 |
| 6 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 3.15797100 |
| 7 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 3.11632269 |
| 8 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.99888000 |
| 9 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.95652670 |
| 10 | Phototransduction_Homo sapiens_hsa04744 | 2.89392770 |
| 11 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.51166569 |
| 12 | Pyruvate metabolism_Homo sapiens_hsa00620 | 2.49068529 |
| 13 | Peroxisome_Homo sapiens_hsa04146 | 2.42325695 |
| 14 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.37972043 |
| 15 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.27583122 |
| 16 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.16607959 |
| 17 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.12576512 |
| 18 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 2.10824610 |
| 19 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.06407477 |
| 20 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.03515230 |
| 21 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.00189380 |
| 22 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.83344588 |
| 23 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.77713554 |
| 24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.72747907 |
| 25 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.68149858 |
| 26 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.63276596 |
| 27 | Carbon metabolism_Homo sapiens_hsa01200 | 1.61814206 |
| 28 | Bile secretion_Homo sapiens_hsa04976 | 1.58272561 |
| 29 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.51818395 |
| 30 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.48911778 |
| 31 | Nicotine addiction_Homo sapiens_hsa05033 | 1.40546720 |
| 32 | Other glycan degradation_Homo sapiens_hsa00511 | 1.31337436 |
| 33 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.31103883 |
| 34 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.30027214 |
| 35 | Lysine degradation_Homo sapiens_hsa00310 | 1.21581863 |
| 36 | Mineral absorption_Homo sapiens_hsa04978 | 1.21572491 |
| 37 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.21409773 |
| 38 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.18911405 |
| 39 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.17013703 |
| 40 | GABAergic synapse_Homo sapiens_hsa04727 | 1.14035585 |
| 41 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.11939065 |
| 42 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.11013347 |
| 43 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.10982589 |
| 44 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.08484811 |
| 45 | Histidine metabolism_Homo sapiens_hsa00340 | 1.07229567 |
| 46 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.04792661 |
| 47 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.03475265 |
| 48 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.02235580 |
| 49 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.98927778 |
| 50 | Gap junction_Homo sapiens_hsa04540 | 0.96055697 |
| 51 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.94173616 |
| 52 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.92960428 |
| 53 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.92500188 |
| 54 | Morphine addiction_Homo sapiens_hsa05032 | 0.91681580 |
| 55 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.90670702 |
| 56 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.90005032 |
| 57 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.89937074 |
| 58 | Bladder cancer_Homo sapiens_hsa05219 | 0.88716805 |
| 59 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.88015907 |
| 60 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.87108573 |
| 61 | Taste transduction_Homo sapiens_hsa04742 | 0.84787366 |
| 62 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.83818090 |
| 63 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.82704085 |
| 64 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.82236753 |
| 65 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.79219673 |
| 66 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.77370760 |
| 67 | Endometrial cancer_Homo sapiens_hsa05213 | 0.71818925 |
| 68 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.71562402 |
| 69 | Glioma_Homo sapiens_hsa05214 | 0.70184178 |
| 70 | Insulin secretion_Homo sapiens_hsa04911 | 0.69374690 |
| 71 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.69231832 |
| 72 | Circadian entrainment_Homo sapiens_hsa04713 | 0.68489482 |
| 73 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.68171081 |
| 74 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.66861739 |
| 75 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.63762441 |
| 76 | Lysosome_Homo sapiens_hsa04142 | 0.63560109 |
| 77 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.63383413 |
| 78 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.63153721 |
| 79 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.62823054 |
| 80 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.61798635 |
| 81 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.61622846 |
| 82 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.60845050 |
| 83 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.60832675 |
| 84 | Salivary secretion_Homo sapiens_hsa04970 | 0.60359810 |
| 85 | Melanoma_Homo sapiens_hsa05218 | 0.59523838 |
| 86 | Long-term depression_Homo sapiens_hsa04730 | 0.59122641 |
| 87 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.57092322 |
| 88 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.56737242 |
| 89 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.56040653 |
| 90 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.53470916 |
| 91 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.52656835 |
| 92 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.51135732 |
| 93 | Metabolic pathways_Homo sapiens_hsa01100 | 0.50251709 |
| 94 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.49721507 |
| 95 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.48354770 |
| 96 | Retinol metabolism_Homo sapiens_hsa00830 | 0.47640268 |
| 97 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.43843177 |
| 98 | Renin secretion_Homo sapiens_hsa04924 | 0.42705692 |
| 99 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.40887577 |
| 100 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.39904591 |
| 101 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.38131187 |
| 102 | Olfactory transduction_Homo sapiens_hsa04740 | 0.37596283 |
| 103 | Long-term potentiation_Homo sapiens_hsa04720 | 0.36157345 |
| 104 | Focal adhesion_Homo sapiens_hsa04510 | 0.35654438 |
| 105 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.35520317 |
| 106 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.35408204 |
| 107 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.34105646 |
| 108 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.33809492 |
| 109 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.32519198 |
| 110 | Parkinsons disease_Homo sapiens_hsa05012 | 0.29642810 |
| 111 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.27659935 |
| 112 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.27347751 |
| 113 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.26499256 |
| 114 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.25778935 |
| 115 | Prostate cancer_Homo sapiens_hsa05215 | 0.25527699 |
| 116 | ABC transporters_Homo sapiens_hsa02010 | 0.24755274 |
| 117 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.24096901 |
| 118 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.22141731 |
| 119 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.22119220 |
| 120 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.21420024 |
| 121 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.19028066 |
| 122 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.16269329 |
| 123 | Sulfur relay system_Homo sapiens_hsa04122 | 0.16138629 |
| 124 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.11083153 |
| 125 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.07108407 |
| 126 | Insulin resistance_Homo sapiens_hsa04931 | 0.07046187 |
| 127 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.06842404 |
| 128 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.06365573 |
| 129 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.04261563 |
| 130 | Alzheimers disease_Homo sapiens_hsa05010 | 0.02934934 |
| 131 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.02230785 |
| 132 | Galactose metabolism_Homo sapiens_hsa00052 | 0.01593400 |
| 133 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.01469731 |
| 134 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.01326320 |
| 135 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | -0.0864609 |
| 136 | Pancreatic secretion_Homo sapiens_hsa04972 | -0.0847837 |
| 137 | Huntingtons disease_Homo sapiens_hsa05016 | -0.0763267 |
| 138 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | -0.0678270 |
| 139 | One carbon pool by folate_Homo sapiens_hsa00670 | -0.0587341 |
| 140 | Glucagon signaling pathway_Homo sapiens_hsa04922 | -0.0201287 |

